Mechanisms of the neuroprotective effect of aspirin after oxygen and glucose deprivation in rat forebrain slices

Neuropharmacology

Volumn 39, Issue 7, 2000, Pages 1309-1318

  Moro, M A ^a   De Alba, J ^a   Cardenas A ^a   De Cristobal J ^a   Leza, J C ^a   Lizasoain, I ^a   Diaz Guerra M J M ^b   Bosca L ^b   Lorenzo, P ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b CSIC   (Spain)

Author keywords

Aspirin; Brain ischaemia; Excitatory amino acids; Glutamate; iNOS; Neuroprotection; Nitric oxide; Nuclear factor B

Indexed keywords

ACETYLSALICYLIC ACID; EXCITATORY AMINO ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOMETACIN; LACTATE DEHYDROGENASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN SYNTHASE; SALICYLATE SODIUM;

ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN SLICE; ENZYME ACTIVITY; FOREBRAIN; GLUCOSE METABOLISM; HYPOXIA; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION; WESTERN BLOTTING;

ANIMALS; ANOXIA; ASPIRIN; BLOTTING, WESTERN; CELL NUCLEUS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOSOL; ELECTROPHORESIS; EXCITATORY AMINO ACIDS; GLUCOSE; L-LACTATE DEHYDROGENASE; MALE; NEUROPROTECTIVE AGENTS; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; PHOSPHOPYRUVATE HYDRATASE; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0034069391     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00226-9     Document Type: Article

References (40)

1. Bezzi P., Carmignoto G., Pasti L., Vesce S., Rossi D., Rizzini B.L., Pozzan T., Volterra A. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature. 391:1998;281-285.
2. Cárdenas A., De Alba J., Moro M.A., Leza J.C., Lorenzo P., Lizasoain I. Protective effect of N-(3-(aminomethyl)benzyl)acetamidine, an inducible nitric oxide synthase inhibitor, in brain slices exposed to oxygen-glucose deprivation. Eur. J. Pharmacol. 354:1998;161-165.
3. Carolei A., Prencipe M., Fiorelli M., Fieschi C. Severity of stroke and aspirin. Neurology. 36:1986;1010-1011.
4. Choi D.W., Maulucci-Gedde M.A., Kriegstein A.R. Glutamate neurotoxicity in cortical cell culture. J. Neurosci. 7:1987;357-368.
5. Choi D.W., Rothman S.M. The role of glutamate neurotoxicity in hypoxic-ischaemic neuronal death. Annu. Rev. Neurosci. 13:1990;171-182.
6. Cortas N.K., Wakid N.W. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin. Chem. 36:1990;1440-1443.
7. De Alba J., Cárdenas A., Moro M.A., Leza J.C., Lorenzo P., Lizasoain I. Use of brain slices in the study of pathogenic role of inducible nitric oxide synthase in cerebral ischaemia-reperfusion. Gen. Pharmacol. 32:1999;577-581.
8. De Alba J., Moro M.A., Leza J.C., Lorenzo P., Boscá L., Lizasoain I. Down-regulation of neuronal NO synthase by NO after oxygen-glucose deprivation in rat forebrain slices. J. Neurochem. 72:1999;248-254.
9. Díaz-Guerra M.J.M., Velasco M., Martín-Sanz P., Boscá L. Evidence for common mechanisms in the transcriptional control of type II nitric oxide synthase in isolated hepatocytes. Requirement of NF-kappaB activation after stimulation with bacterial cell wall products and phorbol esters. J. Biol. Chem. 271:1996;30114-30120.
10. Dirnagl U., Iadecola C., Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22:1999;391-397.
11. Dowling E.J., Symons A.M., Jasani M.K. The ex vivo measurement of malondialdehyde and chemiluminescence as possible indices for anti-inflammatory drug evaluation. Int. J. Tissue React. 9:1987;385-391.
12. 15N] in biological fluids. Anal. Biochem. 126:1982;131-138.
13. Grilli M., Pizzi M., Memo M., Spano F. Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation. Science. 274:1996;1383-1385.
14. Gross S.S., Wolin M.S. Nitric oxide: pathophysiological mechanisms. Annu. Rev. Physiol. 57:1995;737-769.
15. Grotta J.C., Lemak N.A., Gary H., Fields W.S., Vital D. Does platelet antiaggregant therapy lessen the severity of stroke? Neurology. 35:1985;632-636.
16. Guerrini L., Blasi F., Denis-Donini S. Synaptic activation of NF-kappa B by glutamate in cerebellar granule neurons in vitro. Proc. Natl. Acad. Sci. U.S.A. 92:1995;9077-9081.
17. Hill H.D., Straka J.G. Protein determination using bicinchoninic acid in the presence of sulfhydryl reagents. Anal. Biochem. 170:1988;203-208.
18. Joseph R., Han E., Tsering C., Grunfeld S., Welch K.M. Platelet activity and stroke severity. J. Neurol. Sci. 108:1992;1-6.
19. Kaltschmidt C., Kaltschmidt B., Baeuerle P.A. Stimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neurones. Proc. Natl. Acad. Sci. U.S.A. 92:1995;9618-9622.
20. Koh J.Y., Choi D.W. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J. Neurosci. Meth. 20:1987;83-90.
21. Kopp E., Gosh S. Inhibition of NF-κB by sodium salicylate and aspirin. Science. 265:1994;956-959.
22. Kuhn W., Müller T., Büttner T., Gerlach M. Aspirin as a free radical scavenger: Consequences for therapy of cerebrovascular ischemia. Stroke. 26:1995;1959-1960.
23. Lindroth P., Mopper K. High performance liquid chromatographic determination of subpicomole amounts of amino acids by precolumn fluorescence derivatization with o-phtaldialdehyde. Anal. Chem. 51:1979;1667-1674.
24. Marangos P., Schmechel D., Parma A., Clark R., Goodwin F. Measurement of neuron-specific (NSE) and non-neuronal (NNE) isoenzymes of enolase in rat, monkey and human nervous tissue. J. Neurochem. 33:1979;319-329.
25. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: Physiology, Pathophysiology, and Pharmacology. Pharmacol. Rev. 43:1991;109-142.
26. Moro M.A., De Alba J., Leza J.C., Lorenzo P., Fernández A.P., Bentura M.L., Boscá L., Rodrigo J., Lizasoain I. Neuronal expression of inducible nitric oxide synthase after oxygen and glucose deprivation in rat forebrain slices. Eur. J. Neurosci. 10:1998;445-456.
27. Oberle S., Polte T., Abate A., Podhaisky H.P., Schroder H. Aspirin increases ferritin synthesis in endothelial cells: a novel antioxidant pathway. Circ. Res. 82:1998;1016-1020.
28. Påhlman S., Esscher T., Bergvall P., Odelstad L. Purification and characterization of human neuron specific enolase: Radioimmunoassay development. Tumour Biol. 5:1984;127-139.
29. Patrono C. Aspirin as an antiplatelet drug. N. Engl. J. Med. 330:1994;1287-1294.
30. Payan D.G., Katzung B. Antiinflamatorios no esteroides; analgésicos no opioides; antiurémicos. Katzum B.G. Farmacología básica y clínica. 1996;651-678 El Manual Moderno, Mexico.
31. Pekoe G., Van Dyke K., Mengoli H., Peden D., English D. Comparison of the effects of antioxidant non-steroidal anti-inflammatory drugs against myeloperoxidase and hypochlorous acid luminol-enhanced chemiluminescence. Agents Actions. 12:1982;232-238.
32. Rees D.D., Cunha F.Q., Assreuy J., Herman A.G., Moncada S. Sequential induction of nitric oxide synthase by Corynebacterium parvum in different organs of the mouse. Br. J. Pharmacol. 114:1995;689-693.
33. Salminen A., Liu P.K., Hsu C.Y. Alteration of transcription factor binding activities in the ischemic rat brain. Biochem. Biophys. Res. Commun. 212:1995;939-944.
34. 2+-independent nitric oxide synthases. FEBS Lett. 291:1991;145-149.
35. Schreck R., Meier B., Männel D.N., Dröge W., Baeuerle P.A. Dithiocarbamates as potent inhibitors of NFκB activation in intact cells. J. Exp. Med. 175:1992;1181-1194.
36. Schreck R., Albermann K., Baeuerle P. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells. Free Rad. Res. Commun. 17:1992;221-237.
37. Schreiber E., Matthias P., Müller M.M., Schaffner W. Rapid detection of octamer binding proteins with "mini-extracts", prepared from a small number of cells. Nucleic Acid Res. 17:1989;6419.
38. Vane J.R., Botting R.M. Mechanism of action of anti-inflammatory drugs. Scand. J. Rheumatol. 25:1996;9-21.
39. Xie Q.W., Kashiwabara Y., Nathan C. Role of transcription factor NFκB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:1994;4705-4708.
40. Yin M.J., Yamamoto Y., Gaynor R.B. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β Nature. 396:1998;77-80.